Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · IEX Real-Time Price · USD
3.000
+0.090 (3.09%)
At close: Jul 26, 2024, 4:00 PM
2.898
-0.102 (-3.40%)
After-hours: Jul 26, 2024, 6:58 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $626.35 million as of July 26, 2024. Its market cap has decreased by -25.95% in one year.
Market Cap
626.35M
Enterprise Value
214.33M
1-Year Change
-25.95%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.84B to $626.35M, a decrease of -77.96%. That is a compound annual growth rate of -22.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 497.20M | -7.96% |
| Dec 29, 2023 | 540.20M | -40.45% |
| Dec 30, 2022 | 907.10M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | 3.54B | 11.80% |
| Dec 31, 2019 | 3.17B | -3.19% |
| Dec 31, 2018 | 3.27B | 15.10% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 657.70M |
| Emergent BioSolutions | 654.50M |
| Verve Therapeutics | 646.53M |
| Pediatrix Medical Group | 646.25M |
| Celcuity | 646.21M |
| Astria Therapeutics | 640.29M |
| Entrada Therapeutics | 637.82M |
| Arcturus Therapeutics Holdings | 636.13M |